Lawyers for litigation

Regeneron Pharmaceuticals, Inc. v Sandoz Pty Ltd [2025] FCA 1067

Regeneron Pharmaceuticals, Inc. v Sandoz Pty Ltd [2025] FCA 1067

PRACTICE AND PROCEDURE – patents – interlocutory injunction application – prima facie case – infringement – validity of patents – balance of convenience – application refused

PATENTS – aflibercept – VEGF Antagonist – claim construction – infringement – infringing and non-infringing uses – novelty – inventive step – support

Original article available at: https://www.judgments.fedcourt.gov.au/judgments/Judgments/fca/single/2025/2025fca1067For more information, see the original judgement.
Send this to a friend